These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20207367)

  • 1. Neuromuscular disorders associated with Hepatitis B vaccination.
    Stübgen JP
    J Neurol Sci; 2010 May; 292(1-2):1-4. PubMed ID: 20207367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular complications of hepatitis A virus infection and vaccines.
    Stübgen JP
    J Neurol Sci; 2011 Jan; 300(1-2):2-8. PubMed ID: 20920814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated myelitis following hepatitis B vaccination.
    Stübgen JP
    Autoimmun Rev; 2012 Dec; 12(2):144-9. PubMed ID: 22498789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced autoimmunity.
    Cohen AD; Shoenfeld Y
    J Autoimmun; 1996 Dec; 9(6):699-703. PubMed ID: 9115571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM; Langford CA; Sneller MC; Wise RP; Ball R;
    J Rheumatol; 2004 Nov; 31(11):2181-8. PubMed ID: 15517631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous polyarteritis nodosa following hepatitis B vaccination].
    Bourgeais AM; Dore MX; Croue A; Leclech C; Verret JL
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):205-7. PubMed ID: 12671586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic polyarteritis nodosa following hepatitis B vaccination.
    de Carvalho JF; Pereira RM; Shoenfeld Y
    Eur J Intern Med; 2008 Dec; 19(8):575-8. PubMed ID: 19046721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y; Aron-Maor A
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha and neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2009 Feb; 207(1-2):3-17. PubMed ID: 19171385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination and central nervous system demyelination: an immunological approach.
    Piaggio E; Ben Younes A; Desbois S; Gout O; Tourbah A; Lyon-Caen O; Liblau RS
    J Autoimmun; 2005 Feb; 24(1):33-7. PubMed ID: 15725574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extrahepatic manifestations of hepatitis B virus.
    Baig S; Alamgir M
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):451-7. PubMed ID: 18760074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis after general anesthesia and hepatitis B vaccine.
    Biron P; Montpetit P; Infante-Rivard C; Léry L
    Arch Intern Med; 1988 Dec; 148(12):2685. PubMed ID: 2973775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis.
    Geier DA; Geier MR
    Hepatogastroenterology; 2002; 49(48):1571-5. PubMed ID: 12397738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular disorders associated with hepatitis B virus infection.
    Stübgen JP
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):26-37. PubMed ID: 22361623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.
    Mason A; Theal J; Bain V; Adams E; Perrillo R
    Am J Gastroenterol; 2005 Apr; 100(4):972-6. PubMed ID: 15784044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.